Brain expression of AAV-Ifn-γ leads to reactive gliosis, nigrostriatal degeneration and midbrain calcification in wild type mice. This mouse model phenocopies idiopathic basal ganglia calcification which is associated with Parkinsonian symptoms. To understand how the nigro-striatal pathway is selectively vulnerable to Ifn-γ, we determined if the phenotype is driven by canonical signaling intermediates, Ifngr1 and Stat1. Using focused bioinformatic analysis and rotarod testing, we show that neuroinflammation and motor abnormalities precede the appearance of midbrain neuropathologies in the brains of Ifn-γ mouse model. To test whether canonical Ifn-γ signaling is a key driver of progressive nigrostriatal degeneration, we overexpressed Ifn-γ in the brains of Ifngr1 −/− and Stat1 −/− mice. Expression of Ifn-γ in Ifngr1 −/− mice did not result in any neuroinflammation, midbrain calcinosis or nigrostriatal degenerative pathology. Interestingly, in Stat1 −/− mice, Ifn-γ expression resulted in gliosis without recapitulating the neurodegenerative phenotype. Overall, our data shows that canonical Ifn-γ signaling triggers midbrain calcinosis and nigrostriatal neurodegeneration, providing mechanistic insights into cytokine-driven selective neuronal vulnerability. Our study establishes the broader relevance of inflammatory signaling in neurodegenerative diseases and can potentially identify novel immunological targets for Parkinsonian syndromes.
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Introduction
Neurodegenerative proteinopathies such as Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and Alzheimer's disease (AD) show different patterns of selective neurodegeneration. Yet, the proteins that are the presumed etiologic triggers of these diseases are typically widely expressed. Therefore, the differential vulnerability of subsets of neurons to various pathological factors remains an enigma (Gotz et al., 2009; Double et al., 2010; Rosas et al., 2008; Pasinelli and Brown, 2006) . Although numerous hypothesis have been proposed to account for differential neuronal vulnerability, there remains a poor understanding of why one population of cells is more vulnerable to a given neurodegenerative process than another. Understanding differential neuronal vulnerability may provide novel insights into neuroprotective strategies, and thus is of tremendous importance. The most simplistic conceptualization of differential neuronal vulnerability posits that the vulnerability of a given neuronal population is related to both the stressor and the intrinsic response of those neurons to that stressor (Saxena and Caroni, 2011) . Additional factors relating to the local microenvironment (including non-neuronal cells) may also modulate both the strength of the stressor and neuronal response to the stressor determining why one population of neurons is more vulnerable than another.
An invariant feature of neurodegenerative diseases is neuroinflammation, which reflects an underlying innate immune activation state thought to be altered in a defined temporal sequence preceding the onset of the neurodegenerative cascade (Schwartz and Deczkowska, 2016; Wyss-Coray, 2016) . Immune activation has been proposed to be one of the extrinsic modulating factors that can directly trigger selective neuronal degeneration in these neurodegenerative diseases (Saxena and Caroni, 2011) . We have previously demonstrated that recombinant AAV (AAV) mediated expression of mouse Interferon (Ifn)-γ in wild type (WT) mice induces progressive and selective nigrostriatal degeneration and midbrain calcinosis (Chakrabarty et al., 2011 ). This mouse model (AAV-Ifn-γ) phenocopies human idiopathic basal ganglia calcification (IBGC) syndrome, which is a disorder typically characterized 
